Maintaining the safety of clinical trial participants amid COVID-19 and beyond The MyOwnMed ECOS System dovetails with the FDA’s guidance released mid-March, 2020. Let us know if your institution could benefit from a tour of the ECOS Platform.
University of Buffalo works integrates MyOwnMed mobile app into Clinical Trial to Assess Hepatitis C Management in Methadone-Maintained Patients
The MyOwnMed ECOS Platform portal and mobile app are helping Arizona Univ. Center for Innovation in Brain Science in their national multi-site Phase 2 clinical trial in individuals with early-stage Alzheimer’s disease.
Our ECOS Platform components help monitor autoimmune symptoms in the Parker Institute for Cancer Immunotherapy, National Cancer Care Alliance, and Precision Cancer Research
